These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25429208)

  • 1. Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.
    Du YF; Ou HY; Beverly EA; Chiu CJ
    Clin Interv Aging; 2014; 9():1963-80. PubMed ID: 25429208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the patient with advanced complications, functional decline, and persistent hyperglycemia.
    Zettervall DK
    Consult Pharm; 2010 Jun; 25 Suppl B():5-10. PubMed ID: 20726377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.
    Werzowa J; Pacini G; Hecking M; Fidler C; Haidinger M; Brath H; Thomas A; Säemann MD; Tura A
    J Diabetes Complications; 2015; 29(8):1211-6. PubMed ID: 26264400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypoglycemia in older adults with type 2 diabetes.
    Freeman J
    Postgrad Med; 2019 May; 131(4):241-250. PubMed ID: 30724638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
    Garza H
    Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.
    Munshi MN; Slyne C; Segal AR; Saul N; Lyons C; Weinger K
    J Diabetes Complications; 2017 Jul; 31(7):1197-1199. PubMed ID: 28343792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of elderly patients with type 2 diabetes mellitus.
    Pratley RE; Gilbert M
    Postgrad Med; 2012 Jan; 124(1):133-43. PubMed ID: 22314123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?
    Triplitt C
    Consult Pharm; 2010 Jun; 25 Suppl B():19-27. PubMed ID: 20726379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assisted living: improving glucose control for the functionally independent patient with diabetes.
    Zettervall DK
    Consult Pharm; 2010 Jun; 25 Suppl B():28-35. PubMed ID: 20726380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
    Casagrande S; Cowie CC; Fradkin JE
    J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of clinical judgment and guidelines to achieving glycemic goals in type 2 diabetes: focus on pharmacologic therapy.
    Yacoub TG
    Postgrad Med; 2014 May; 126(3):95-106. PubMed ID: 24918795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
    Hong EG; Min KW; Lim JS; Ahn KJ; Ahn CW; Yu JM; Kim HS; Kim HJ; Kim W; Kim DH; Jang HC
    Adv Ther; 2024 May; 41(5):1967-1982. PubMed ID: 38512540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
    Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
    J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of timely basal insulin control in patients with type 2 diabetes.
    Lovre D; Fonseca V
    J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.